Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Harvard Business School
QuintilesIMS
Johnson and Johnson
Teva
Express Scripts
Merck
US Army
Medtronic

Generated: April 24, 2018

DrugPatentWatch Database Preview

ANGIOVIST 292 Drug Profile

« Back to Dashboard

When do Angiovist 292 patents expire, and what generic alternatives are available?

Angiovist 292 is a drug marketed by Bayer Hlthcare and is included in one NDA.

The generic ingredient in ANGIOVIST 292 is diatrizoate meglumine; diatrizoate sodium. There are nine drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the diatrizoate meglumine; diatrizoate sodium profile page.
Summary for ANGIOVIST 292
Drug patent expirations by year for ANGIOVIST 292

US Patents and Regulatory Information for ANGIOVIST 292

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bayer Hlthcare ANGIOVIST 292 diatrizoate meglumine; diatrizoate sodium INJECTABLE;INJECTION 087724-001 Sep 23, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
US Army
US Department of Justice
Federal Trade Commission
Harvard Business School
Fuji
Farmers Insurance
Baxter
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.